Skip to main content
Frontiers in Medicine logoLink to Frontiers in Medicine
. 2025 Aug 29;12:1685872. doi: 10.3389/fmed.2025.1685872

Correction: Diagnosis and treatment of pulmonary Aspergillus infection secondary to empyema complicated with lung cancer: a case report

Chen Zhu 1,, Xiuli Liu 1,, Ying Gu 1, Yuyao Shen 1,*, Tingshu Jiang 1,*
PMCID: PMC12425795  PMID: 40950997

The reference details for (2), (9), (10), and (11) were erroneously written as:

  • 2. Wu T, Li P, Wang M, Wang Q, et al. Pulmonary solid tumor with coexisting pulmonary aspergillosis: case reports and literature review. Clin Respir J. 2017;11(1):3-12. doi: 10.1111/crj.12345

  • 9. Smith J Brown A Johnson R Kirkevold Ø Halvorsen TO. Fungal empyema in lung cancer patients: a retrospective analysis. J Thorac Oncol. (2023) 18:123–30. doi: 10.1016/j.jtho.2023.01.012

  • 10. Lee H Kim S Park J Park JE Jung SS Na JO et al. Invasive pulmonary aspergillosis complicated by empyema in non-small cell lung cancer: a case series. Mycopathologia. (2022) 187:259–69. doi: 10.1007/s11046-022-00623-y, PMID: 35314920

  • 11. Wang X Liu Y Chen Z Zhou C Zhang J Chen Q et al. Combined antifungal and antitumor therapy for aspergillus empyema in lung cancer: a retrospective analysis. Front Oncol. (2022) 12:876543. doi: 10.3389/fonc.2022.876543

It should be Wu et al. (2), Nigo et al. (9), Koulenti et al. (10), and Marr et al. (11).

The correct references are as follows:

  • 2. Wu T, Li P, Wang M, Wang Q, Shi Y, Su X. Pulmonary solid tumor with coexisting pulmonary aspergillosis: case reports and literature review. Clin Respir J. (2017) 11:3–12. doi: 10.1111/crj.12294

  • 9. Nigo M, Vial MR, Munita JM, Jiang Y, Tarrand J, Jimenez CA, et al. Fungal empyema thoracis in cancer patients. J Infect. (2016) 72:615–21. doi: 10.1016/j.jinf.2016.02.014

  • 10. Koulenti D, Garnacho-Montero J, Blot S. Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis. (2014) 27:174–83. doi: 10.1097/QCO.0000000000000043

  • 11. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. (2004) 39:797–802. doi: 10.1086/423380

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 2.Wu T, Li P, Wang M, Wang Q, Shi Y, Su X. Pulmonary solid tumor with coexisting pulmonary aspergillosis: case reports and literature review. Clin Respir J. (2017) 11:3–12. 10.1111/crj.12294 [DOI] [PubMed] [Google Scholar]
  • 9.Nigo M, Vial MR, Munita JM, Jiang Y, Tarrand J, Jimenez CA, et al. Fungal empyema thoracis in cancer patients. J Infect. (2016) 72:615–21. 10.1016/j.jinf.2016.02.014 [DOI] [PubMed] [Google Scholar]
  • 10.Koulenti D, Garnacho-Montero J, Blot S. Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis. (2014) 27:174–83. 10.1097/QCO.0000000000000043 [DOI] [PubMed] [Google Scholar]
  • 11.Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. (2004) 39:797–802. 10.1086/423380 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Medicine are provided here courtesy of Frontiers Media SA

RESOURCES